For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
Phase:
PHASE4
Details
Lead Sponsor:
Duke University
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)